Lignocaine (Lidocaine)

Lignocaine (Lidocaine) Hydrochloride Gel 2% w/v is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Janaushadhi Suraksha Adhesive Bandages (Washproof) and Antiseptic Bandage Spray (Cetrimide 0.10% + Lidocaine 1.0%) is an essential first-aid wound dressing product on the PMBI Formulary. Suraksha strips feature an absorbent non-adherent wound pad impregnated with antiseptic, backed by a microperforated water-repellent adhesive film that protects cuts from water and dirt while allowing skin respiration. Antiseptic spray delivers instant surface local anesthesia and bactericidal protection with a quick-drying protective transparent film. Indicated for minor cuts, scrapes, abrasions, lacerations, and blister protection.

Gabapentin, Lignocaine (Lidocaine), and Baclofen topical gel is a localized multi-modal compound for refractory neuropathic and musculoskeletal pain. Gabapentin provides regional neuro-inhibition via calcium channel modulation; lignocaine reversibly blocks neuronal sodium channels to arrest pain impulse conduction; and baclofen activates GABAB receptors, inducing local skeletal muscle relaxation and mitigating spastic myofascial trigger points. Indicated for localized post-herpetic neuralgia, superficial neuropathic pain, and focal myofascial pain syndromes.

Lignocaine (Lidocaine) and Nifedipine topical cream is a specialized anorectal formulation. Lignocaine reversibly blocks neuronal sodium channels to provide rapid local analgesia, relieving severe anal pain and spasm, while nifedipine, a calcium channel blocker, relaxes the hypertonic internal anal sphincter muscle, reducing resting anal pressure and enhancing local mucosal blood perfusion to promote tissue healing. Indicated for the conservative medical management of acute and chronic anal fissures.

Lignocaine 2.5% & Prilocaine 2.5% Topical Gel (EMLA) is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Lignocaine (4% w/w), Metronidazole (1% w/w), and Sucralfate (7% w/w) Cream is a specialized topical rectal formulation. Lignocaine produces rapid local analgesia by blocking voltage-gated sodium channels. Metronidazole provides topical antimicrobial activity against anaerobic rectal flora, reducing secondary infection and inflammation. Sucralfate forms an adhesive barrier over mucosal fissures and hemorrhoidal ulcers, accelerating re-epithelialization and tissue healing. Indicated for acute and chronic anal fissures, painful thrombosed hemorrhoids, and post-hemorrhoidectomy wound healing.

Mouth Ulcer Gel (Choline Salicylate 8.7%-9% w/w, Benzalkonium Chloride 0.01% w/w, with or without Lignocaine 2% w/w) is a topical analgesic, anti-inflammatory, and antiseptic oral gel on the PMBI formulary. Choline salicylate is a topically absorbed non-steroidal anti-inflammatory that inhibits cyclooxygenase enzymes to relieve throbbing ulcer pain and swelling. Lignocaine produces rapid surface local anesthesia by blocking mucosal voltage-gated sodium channels. Benzalkonium chloride acts as a cationic surfactant bactericide, preventing secondary infection. Indicated for aphthous mouth ulcers, canker sores, denture sores, orthodontic abrasions, and herpes labialis irritation.